This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Inhaled Nitric Oxide Delivery Systems Market

Respiratory Diseases on Surge, Elevating Sales of Inhaled Nitric Oxide Delivery Systems: Opportunities ahead

Inhaled Nitric Oxide Delivery Systems Market by Product Type, Type, Application, End User & Region - Forecast 2022 - 2032

Inhaled Nitric Oxide Delivery Systems Outlook (2022-2032)

In 2021, the Global Inhaled Nitric Oxide Delivery Systems market was estimated to be worth around US$ 273.7 Mn. With the increasing expenditure incurred on treating respiratory diseases with Inhaled Nitric Oxide Delivery Systems worldwide, the market is expected to reach a worth of about US$ 735.7 Mn by the end of 2032, with a projected CAGR of 9.5% during 2022 – 2032. From 2017 to 2021, the Inhaled Nitric Oxide Delivery Systems Market experienced a growth of 8.5%.

Attributes

Details

Global Inhaled Nitric Oxide Delivery Systems Market Size (2021)

US$ 273.7 Mn

Global Inhaled Nitric Oxide Delivery Systems Market Size (2022)

US$ 297.3 Mn

Projected Market Value (2032)

US$ 735.7 Mn

Global Market Growth Rate (2022-2032)

9.5% CAGR

United States Inhaled Nitric Oxide Delivery Systems Market (2022)

US$ 104.7 Mn

Key Companies Profiled

  • Mallinckrodt Pharmaceuticals
  • Getinge
  • Vero Biotech
  • LINDE
  • Beyond Air
  • SLE
  • NU MED
  • Bellerophon Therapeutics
  • Air Liquide Healthcare
  • Circassia Pharmaceuticals

More than 50% of patients with respiratory diseases need hospital admission. Increased R&D efforts that result in novel applications for inhaled nitric oxide delivery systems in the healthcare sector are the key factor fuelling the growth of the global inhaled nitric oxide delivery systems market. In addition, an aging population with weakened lung function drives the demand for inhaled nitric oxide delivery systems globally.

Nitric oxide inhalation (INO), a minimally invasive therapy, is becoming more popular, which is causing the market to grow. Research conducted in 2020 revealed that inhaled nitric oxide is effective in treating SARS-CoV-2 infection. Like traditional medications, it is also a successful therapy for COVID-19 patients. As a result, during the pandemic, there was a sharp increase in demand for inhaled nitric oxide delivery systems.

Additionally, ARDS (acute respiratory distress syndrome), a symptom in COVID-19 patients, is well treated with inhaled nitric oxide delivery systems. INO helps COVID-19 patients by increasing oxygen circulation. These factors are therefore expected to improve the opportunities for market growth for inhaled nitric oxide delivery systems. Important market participants like Mallinckrodt Pharmaceuticals are sponsoring more clinical trials of inhaled nitric oxide therapy.

During the following ten years, these activities will also drive the market's expansion. The year 2020 saw an overwhelming demand for Inhaled Nitric oxide delivery systems due to increasing cases of Covid-19.

Customize this Report

Let us know your requirement to get
100% FREE customization

Region-wise Insights

Which region holds the largest market for Inhaled Nitric Oxide Delivery Systems?

North America holds the largest market for Inhaled Nitric Oxide Delivery Systems and is likely to grow at a rapid pace in the next 10 years. This growth is because of the increasing cases of HRF in the region. In addition to this, the rising adoption of the INO therapy, the presence of advanced medical infrastructure, and favorable government initiatives are expected to bolster growth avenues in the market.

Asthma affects more than 25 million people in the United States. 12 million adults have not yet received a COPD diagnosis, despite there being 14.8 million adults with the condition. In the United States, phase two and phase three clinical trials of inhaled nitric oxide for acute respiratory distress syndrome use the inhaled nitric oxide delivery method on a regular basis.

In 2020, more than 300,000 deaths from respiratory disorders were recorded in Canada. Five significant respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), and cystic fibrosis, afflict the majority of Canadians. As these illnesses become more prevalent, the need for inhaled nitric oxide delivery systems in the area is growing along with them.

Which region is expected to see significant growth in the future for Inhaled Nitric Oxide Delivery Systems Market?

Asia Pacific has the fasted growing market for Inhaled Nitric Oxide Delivery Systems. This is mainly due to the increasing pollution and growing pediatric population in the region.

In Asia Pacific, China accounts for the largest share of the market for Inhaled Nitric Oxide Delivery Systems followed by India. This is because COPD is rapidly becoming recognized as a severe health issue in China. According to estimations, 8.2% of Chinese people have COPD, and the disease's death rate is around 1.6%.

In India, respiratory infections caused 41,996,260 illnesses and 3,740 deaths in 2018, according to the National Health Portal of India. Severe acute respiratory infections (SARI) are one of the leading causes of death in children under the age of five, accounting for 18% of the global population in India. As a result, there is a sharp rise in the demand for inhaled nitric oxide delivery systems in the country.

Country-wise Insights

U.S. Inhaled Nitric Oxide Delivery Systems Market Analysis

The United States holds the largest market for Inhaled Nitric Oxide Delivery Systems, which is projected to reach a valuation of US$ 258.4 Mn by 2032. From 2017 to 2021, the market in the US grew at a CAGR of 8.8%. Between 2022 and 2032, the US is expected to be a market with a US$ 153.7 Mn absolute dollar opportunity.

Since there are between 64.2 and 78.9 cases of ARDS per 100,000 people per year in the US, there exists a significant demand for Inhaled Nitric Oxide Delivery systems. Around 25% of ARDS patients are initially categorized as mild, with the remaining 75% being categorized as moderate or severe. A sickness that is moderate or severe develops in one-third of mild cases.

A further estimate places the annual number of term and late-preterm newborns in the United States with HRF at 80,000. In neonatal intensive care units (NICUs), respiratory morbidity affects about 15% of term newborns and 29% of late-preterm infants. These are the key reasons for the increasing demand for Inhaled Nitric Oxide Delivery Systems in the country.

China Inhaled Nitric Oxide Delivery Systems Market Analysis

In 2021, the market size of China is comparatively small. It was the second-largest Inhaled Nitric Oxide Delivery Systems Market after the US. The market in the country is expected to reach a valuation of US$ 88.4 Mn by 2032. From 2017 to 2021, the market in China experienced a CAGR of 9.9% and is expected to experience a CAGR of 10.7% with an absolute dollar opportunity of US$ 56.4 Mn.

With the increasing number of smokers in the country, respiratory diseases are also becoming quite common. In China, almost 1 million people know of COPD, which presents a significant opportunity for INO delivery systems marketers, as inhalation of nitric oxide has been clinically proven to improve the oxygenation of arterial blood flow and limit the amount of mechanical assisted breathing treatments in patients with severe acute respiratory syndrome (SARS).

U.K. Inhaled Nitric Oxide Delivery Systems Market Analysis

The inhaled nitric oxide delivery systems market in the U.K. was held at US$ 12.3 Mn in 2021. The market is projected to reach a valuation of US$ 37.4 Mn by 2032. The U.K. market is expected to witness an absolute dollar opportunity of US$ 24 Mn.

Japan Inhaled Nitric Oxide Delivery Systems Market Analysis

The inhaled nitric oxide delivery systems market in Japan is estimated at US$ 9.1 Mn in 2022. The market in the country is projected to reach a valuation of US$ 21.2 Mn by 2032. During 2022 – 2032, the market is expected to gross an absolute dollar opportunity of US$ 12.1 Mn, growing at a CAGR of 8.8%.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Category-wise Insights

Why Inhaled Nitric Oxide Delivery Systems Market Generates Highest Revenue through Pediatrics?

Inhaled Nitric Oxide Delivery Systems are used the most among pediatrics. From 2017 to 2021, the use of INO Delivery Systems among pediatrics experienced a CAGR of 8.9% and is expected to witness a CAGR of 9.8% in the next ten years.

Inhaled nitric oxide has been significantly effective in the treatment of neonatal diseases such as hypoxic respiratory failure (HRF). In the United States alone, over 25,000 to 30,000 newborn HRF cases are recorded each year, wherein Inhaled Nitric Oxide Delivery System is used for treatment to cure more than half of them.

Why Inhaled Nitric Oxide Delivery Systems Market is Gaining Traction in the Treatment of Hypoxic Respiratory Failure?

Inhaled Nitric Oxide Delivery Systems are used the most in the treatment of Hypoxic Respiratory Failure. The use of the INO delivery system in the treatment of HRF from the year 2017 to 2021 experienced a CAGR of 8.8% and is projected to experience a CAGR of 9.6% from 2022 to 2032.

In 2020, the treatment of Hypoxic Respiratory Failure using Inhaled Nitric Oxide Delivery Systems made up 80.2% of the overall market. Around 2% of all live births and those affected by HRF is also responsible for more than 33% of all neonatal deaths. The death of 18 out of every 1,000 newborns, the majority of whom are born prematurely in the United States, is due to the HRF. According to studies, Inhaled Nitric Oxide is used as the first line of treatment for HRF and it can be used for more than 10 days without causing complications.

Competitive Landscape

The Inhaled Nitric Oxide Delivery Systems market is moderately competitive and has numerous players. With the growing demand for Inhaled Nitric Oxide Systems, new player are also entering the market. The key companies operating in the Inhaled Nitric Oxide Delivery Systems Market are Mallinckrodt Pharmaceuticals, Getinge, VERO Biotech, LINDE, Beyond Air, SLE, NU MED, Bellerophon Therapeutics, Air Liquide Healthcare, and Circassia Pharmaceuticals.

Some of the recent developments by the key providers of Inhaled Nitric Oxide Delivery Systems are as follows:

  • In January 2021, VERO Biotech secured a loan of US$ 50 Mn from Runway Growth Capital LLC to help the further development of GENOSYL Delivery System, which is a tankless Inhaled Nitric Oxide Delivery System, approved by the U.S. Food and Drug Administration.
  • In January 2019, Circassia Pharmaceuticals obtained exclusive marketing rights to AirNOvent in the US and China.
MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Key Segments Covered in Inhaled Nitric Oxide Delivery Systems Market Survey

Inhaled Nitric Oxide Delivery Systems Market by Type:

  • Pediatrics
  • Adult

Inhaled Nitric Oxide Delivery Systems Market by Application:

  • Hypoxic Respiratory Failure (HRF)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Other Applications

Inhaled Nitric Oxide Delivery Systems Market by End User:

  • Hospitals
  • Ambulatory Centres
  • Clinics

Inhaled Nitric Oxide Delivery Systems Market by Product Type:

  • Disposables
  • System

Inhaled Nitric Oxide Delivery Systems Market by Region:

  • North America
  • Europe
  • APAC
  • MEA
  • Latin America

Frequently Asked Questions

The global Inhaled Nitric Oxide Delivery Systems Market was valued at US$ 273.7 Mn in 2021 and is expected to account for an absolute dollar opportunity of US$ 438.4 Mn by 2032.

Over the projected period, the Inhaled Nitric Oxide Delivery Systems Market is expected to increase at a CAGR of 9.5%, reaching a value of US$ 735.7 Mn by 2032.

The growing number of respiratory diseases among all age groups especially during the pandemic is driving the market for Inhaled Oxide Delivery Systems.

The Inhaled Nitric Oxide Delivery Systems Market expanded at a CAGR of 8.5% from 2017 through 2021.

Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, SLE, NU MED, Bellerophon Therapeutics, Air Liquide Healthcare, and Circassia Pharmaceuticals, are some of the key players in the Inhaled Nitric Oxide Delivery Systems Industry.

The US, UK, China, Japan and South Korea are expected to drive the most Inhaled Nitric Oxide Delivery Systems.

The US accounts for the largest market for Inhaled Nitric Oxide Delivery Systems.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2022-2032

        5.3.1. Pediatrics

        5.3.2. Adult

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022-2032

        6.3.1. Hypoxic Respiratory Failure (HRF)

        6.3.2. Acute Hypoxemic Respiratory Failure (AHRF)

        6.3.3. Other Applications

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032

        7.3.1. Hospitals

        7.3.2. Ambultory Centres

        7.3.3. Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021

    8.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032

        8.3.1. Disposables

        8.3.2. System

    8.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021

    8.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021

    9.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Type

        10.2.3. By Application

        10.2.4. By End User

        10.2.5. By Product Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By Application

        10.3.4. By End User

        10.3.5. By Product Type

    10.4. Key Takeaways

11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Type

        11.2.3. By Application

        11.2.4. By End User

        11.2.5. By Product Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By Application

        11.3.4. By End User

        11.3.5. By Product Type

    11.4. Key Takeaways

12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. U.K.

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Type

        12.2.3. By Application

        12.2.4. By End User

        12.2.5. By Product Type

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By Application

        12.3.4. By End User

        12.3.5. By Product Type

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

            13.2.1.4. Malaysia

            13.2.1.5. Singapore

            13.2.1.6. Australia

            13.2.1.7. New Zealand

            13.2.1.8. Rest of APAC

        13.2.2. By Type

        13.2.3. By Application

        13.2.4. By End User

        13.2.5. By Product Type

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By Application

        13.3.4. By End User

        13.3.5. By Product Type

    13.4. Key Takeaways

14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Type

        14.2.3. By Application

        14.2.4. By End User

        14.2.5. By Product Type

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By Application

        14.3.4. By End User

        14.3.5. By Product Type

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Type

            15.1.2.2. By Application

            15.1.2.3. By End User

            15.1.2.4. By Product Type

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Type

            15.2.2.2. By Application

            15.2.2.3. By End User

            15.2.2.4. By Product Type

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Type

            15.3.2.2. By Application

            15.3.2.3. By End User

            15.3.2.4. By Product Type

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Type

            15.4.2.2. By Application

            15.4.2.3. By End User

            15.4.2.4. By Product Type

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Type

            15.5.2.2. By Application

            15.5.2.3. By End User

            15.5.2.4. By Product Type

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Type

            15.6.2.2. By Application

            15.6.2.3. By End User

            15.6.2.4. By Product Type

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Type

            15.7.2.2. By Application

            15.7.2.3. By End User

            15.7.2.4. By Product Type

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Type

            15.8.2.2. By Application

            15.8.2.3. By End User

            15.8.2.4. By Product Type

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Type

            15.9.2.2. By Application

            15.9.2.3. By End User

            15.9.2.4. By Product Type

    15.10. China

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Type

            15.10.2.2. By Application

            15.10.2.3. By End User

            15.10.2.4. By Product Type

    15.11. Japan

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Type

            15.11.2.2. By Application

            15.11.2.3. By End User

            15.11.2.4. By Product Type

    15.12. South Korea

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Type

            15.12.2.2. By Application

            15.12.2.3. By End User

            15.12.2.4. By Product Type

    15.13. Malaysia

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Type

            15.13.2.2. By Application

            15.13.2.3. By End User

            15.13.2.4. By Product Type

    15.14. Singapore

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Type

            15.14.2.2. By Application

            15.14.2.3. By End User

            15.14.2.4. By Product Type

    15.15. Australia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Type

            15.15.2.2. By Application

            15.15.2.3. By End User

            15.15.2.4. By Product Type

    15.16. New Zealand

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Type

            15.16.2.2. By Application

            15.16.2.3. By End User

            15.16.2.4. By Product Type

    15.17. GCC Countries

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Type

            15.17.2.2. By Application

            15.17.2.3. By End User

            15.17.2.4. By Product Type

    15.18. South Africa

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Type

            15.18.2.2. By Application

            15.18.2.3. By End User

            15.18.2.4. By Product Type

    15.19. Israel

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Type

            15.19.2.2. By Application

            15.19.2.3. By End User

            15.19.2.4. By Product Type

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By Application

        16.3.4. By End User

        16.3.5. By Product Type

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Mallinckrodt Pharmaceuticals

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Getinge

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Vero Biotech

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. LINDE

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Beyond Air

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. SLE

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. NU MED

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Bellerophon Therapeutics

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Air Liquide Healthcare

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Circassia Pharmaceuticals

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Volume (Units) Forecast by Region, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 4: Global Market Volume (Units) Forecast by Type, 2017-2032

Table 5: Global Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 6: Global Market Volume (Units) Forecast by Application, 2017-2032

Table 7: Global Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 8: Global Market Volume (Units) Forecast by End User, 2017-2032

Table 9: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 10: Global Market Volume (Units) Forecast by Product Type, 2017-2032

Table 11: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: North America Market Volume (Units) Forecast by Country, 2017-2032

Table 13: North America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 14: North America Market Volume (Units) Forecast by Type, 2017-2032

Table 15: North America Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 16: North America Market Volume (Units) Forecast by Application, 2017-2032

Table 17: North America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 18: North America Market Volume (Units) Forecast by End User, 2017-2032

Table 19: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 20: North America Market Volume (Units) Forecast by Product Type, 2017-2032

Table 21: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: Latin America Market Volume (Units) Forecast by Country, 2017-2032

Table 23: Latin America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 24: Latin America Market Volume (Units) Forecast by Type, 2017-2032

Table 25: Latin America Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 26: Latin America Market Volume (Units) Forecast by Application, 2017-2032

Table 27: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 28: Latin America Market Volume (Units) Forecast by End User, 2017-2032

Table 29: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 30: Latin America Market Volume (Units) Forecast by Product Type, 2017-2032

Table 31: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: Europe Market Volume (Units) Forecast by Country, 2017-2032

Table 33: Europe Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 34: Europe Market Volume (Units) Forecast by Type, 2017-2032

Table 35: Europe Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 36: Europe Market Volume (Units) Forecast by Application, 2017-2032

Table 37: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 38: Europe Market Volume (Units) Forecast by End User, 2017-2032

Table 39: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 40: Europe Market Volume (Units) Forecast by Product Type, 2017-2032

Table 41: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 42: Asia Pacific Market Volume (Units) Forecast by Country, 2017-2032

Table 43: Asia Pacific Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 44: Asia Pacific Market Volume (Units) Forecast by Type, 2017-2032

Table 45: Asia Pacific Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 46: Asia Pacific Market Volume (Units) Forecast by Application, 2017-2032

Table 47: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 48: Asia Pacific Market Volume (Units) Forecast by End User, 2017-2032

Table 49: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 50: Asia Pacific Market Volume (Units) Forecast by Product Type, 2017-2032

Table 51: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 52: MEA Market Volume (Units) Forecast by Country, 2017-2032

Table 53: MEA Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 54: MEA Market Volume (Units) Forecast by Type, 2017-2032

Table 55: MEA Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 56: MEA Market Volume (Units) Forecast by Application, 2017-2032

Table 57: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 58: MEA Market Volume (Units) Forecast by End User, 2017-2032

Table 59: MEA Market Value (US$ Mn) Forecast by Product Type, 2017-2032

Table 60: MEA Market Volume (Units) Forecast by Product Type, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Application, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Market Value (US$ Mn) by Product Type, 2022-2032

Figure 5: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 6: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 7: Global Market Volume (Units) Analysis by Region, 2017-2032

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 11: Global Market Volume (Units) Analysis by Type, 2017-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 15: Global Market Volume (Units) Analysis by Application, 2017-2032

Figure 16: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 17: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 18: Global Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 19: Global Market Volume (Units) Analysis by End User, 2017-2032

Figure 20: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 21: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 22: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 23: Global Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 24: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 25: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 26: Global Market Attractiveness by Type, 2022-2032

Figure 27: Global Market Attractiveness by Application, 2022-2032

Figure 28: Global Market Attractiveness by End User, 2022-2032

Figure 29: Global Market Attractiveness by Product Type, 2022-2032

Figure 30: Global Market Attractiveness by Region, 2022-2032

Figure 31: North America Market Value (US$ Mn) by Type, 2022-2032

Figure 32: North America Market Value (US$ Mn) by Application, 2022-2032

Figure 33: North America Market Value (US$ Mn) by End User, 2022-2032

Figure 34: North America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 35: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 36: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 37: North America Market Volume (Units) Analysis by Country, 2017-2032

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 40: North America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 41: North America Market Volume (Units) Analysis by Type, 2017-2032

Figure 42: North America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 43: North America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 44: North America Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 45: North America Market Volume (Units) Analysis by Application, 2017-2032

Figure 46: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 47: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 48: North America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 49: North America Market Volume (Units) Analysis by End User, 2017-2032

Figure 50: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 51: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 52: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 53: North America Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 54: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 55: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 56: North America Market Attractiveness by Type, 2022-2032

Figure 57: North America Market Attractiveness by Application, 2022-2032

Figure 58: North America Market Attractiveness by End User, 2022-2032

Figure 59: North America Market Attractiveness by Product Type, 2022-2032

Figure 60: North America Market Attractiveness by Country, 2022-2032

Figure 61: Latin America Market Value (US$ Mn) by Type, 2022-2032

Figure 62: Latin America Market Value (US$ Mn) by Application, 2022-2032

Figure 63: Latin America Market Value (US$ Mn) by End User, 2022-2032

Figure 64: Latin America Market Value (US$ Mn) by Product Type, 2022-2032

Figure 65: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 66: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 67: Latin America Market Volume (Units) Analysis by Country, 2017-2032

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 70: Latin America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 71: Latin America Market Volume (Units) Analysis by Type, 2017-2032

Figure 72: Latin America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 74: Latin America Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 75: Latin America Market Volume (Units) Analysis by Application, 2017-2032

Figure 76: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 78: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 79: Latin America Market Volume (Units) Analysis by End User, 2017-2032

Figure 80: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 82: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 83: Latin America Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 84: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 85: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 86: Latin America Market Attractiveness by Type, 2022-2032

Figure 87: Latin America Market Attractiveness by Application, 2022-2032

Figure 88: Latin America Market Attractiveness by End User, 2022-2032

Figure 89: Latin America Market Attractiveness by Product Type, 2022-2032

Figure 90: Latin America Market Attractiveness by Country, 2022-2032

Figure 91: Europe Market Value (US$ Mn) by Type, 2022-2032

Figure 92: Europe Market Value (US$ Mn) by Application, 2022-2032

Figure 93: Europe Market Value (US$ Mn) by End User, 2022-2032

Figure 94: Europe Market Value (US$ Mn) by Product Type, 2022-2032

Figure 95: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 96: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 97: Europe Market Volume (Units) Analysis by Country, 2017-2032

Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 100: Europe Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 101: Europe Market Volume (Units) Analysis by Type, 2017-2032

Figure 102: Europe Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 103: Europe Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 104: Europe Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 105: Europe Market Volume (Units) Analysis by Application, 2017-2032

Figure 106: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 107: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 108: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 109: Europe Market Volume (Units) Analysis by End User, 2017-2032

Figure 110: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 111: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 112: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 113: Europe Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 114: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 115: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 116: Europe Market Attractiveness by Type, 2022-2032

Figure 117: Europe Market Attractiveness by Application, 2022-2032

Figure 118: Europe Market Attractiveness by End User, 2022-2032

Figure 119: Europe Market Attractiveness by Product Type, 2022-2032

Figure 120: Europe Market Attractiveness by Country, 2022-2032

Figure 121: Asia Pacific Market Value (US$ Mn) by Type, 2022-2032

Figure 122: Asia Pacific Market Value (US$ Mn) by Application, 2022-2032

Figure 123: Asia Pacific Market Value (US$ Mn) by End User, 2022-2032

Figure 124: Asia Pacific Market Value (US$ Mn) by Product Type, 2022-2032

Figure 125: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 126: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 127: Asia Pacific Market Volume (Units) Analysis by Country, 2017-2032

Figure 128: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 129: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 130: Asia Pacific Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 131: Asia Pacific Market Volume (Units) Analysis by Type, 2017-2032

Figure 132: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 133: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 134: Asia Pacific Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 135: Asia Pacific Market Volume (Units) Analysis by Application, 2017-2032

Figure 136: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 137: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 138: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 139: Asia Pacific Market Volume (Units) Analysis by End User, 2017-2032

Figure 140: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 141: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 142: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 143: Asia Pacific Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 144: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 145: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 146: Asia Pacific Market Attractiveness by Type, 2022-2032

Figure 147: Asia Pacific Market Attractiveness by Application, 2022-2032

Figure 148: Asia Pacific Market Attractiveness by End User, 2022-2032

Figure 149: Asia Pacific Market Attractiveness by Product Type, 2022-2032

Figure 150: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 151: MEA Market Value (US$ Mn) by Type, 2022-2032

Figure 152: MEA Market Value (US$ Mn) by Application, 2022-2032

Figure 153: MEA Market Value (US$ Mn) by End User, 2022-2032

Figure 154: MEA Market Value (US$ Mn) by Product Type, 2022-2032

Figure 155: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 156: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 157: MEA Market Volume (Units) Analysis by Country, 2017-2032

Figure 158: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 159: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 160: MEA Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 161: MEA Market Volume (Units) Analysis by Type, 2017-2032

Figure 162: MEA Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 163: MEA Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 164: MEA Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 165: MEA Market Volume (Units) Analysis by Application, 2017-2032

Figure 166: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 167: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 168: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 169: MEA Market Volume (Units) Analysis by End User, 2017-2032

Figure 170: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 171: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 172: MEA Market Value (US$ Mn) Analysis by Product Type, 2017-2032

Figure 173: MEA Market Volume (Units) Analysis by Product Type, 2017-2032

Figure 174: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032

Figure 175: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032

Figure 176: MEA Market Attractiveness by Type, 2022-2032

Figure 177: MEA Market Attractiveness by Application, 2022-2032

Figure 178: MEA Market Attractiveness by End User, 2022-2032

Figure 179: MEA Market Attractiveness by Product Type, 2022-2032

Figure 180: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Nitric Oxide Asthma Testing Market

Published : July 2020

Healthcare

Bone Cement Delivery Systems Market

Published : June 2019

Healthcare

Dental Anesthesia Delivery Systems Market

Published : January 2018

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Google translate

Inhaled Nitric Oxide Delivery Systems Market